Завод ДИОД DIOD

Quartalsbericht 2025-Q4
hinzugefügt 10.08.2026

Завод ДИОД Kennzahlen 2025-2007 | DIOD

Kurzer Überblick über die Finanzkennzahlen von Завод ДИОД

Aktuelle Werte werden mit der eigenen Fünfjahreshistorie des Unternehmens für 2019–2023 verglichen.

Die aktuelle Gruppe der Bewertungskennzahlen lautet P/E 171,2x (Median 17,39x), EV/EBITDA 62,85x (Median 8,22x), P/S 2x (Median 2x). Die Multiplikatoren liegen im Mittel 360,7% über ihren Medianen. Ein großer Teil positiver Erwartungen kann eingepreist sein.

Beim aktuellen KGV beträgt die inverse Gewinnrendite 0,6%, eine Brücke zwischen Preis und Unternehmensgewinn.

Die Renditekennzahlen am Periodenende sind ROE -11,1%, ROA -7,3%, ROCE -8,5%. Renditen unter null bedeuten, dass Ressourcen keinen positiven Gewinn erzeugen. Die Erholung bleibt der wichtigste Faktor.

Current und Quick Ratio liegen bei 6,72x und 4,22x. Die Bilanz besitzt komfortable Liquidität.

Der Cash Conversion Cycle stieg von 603,6 Tage auf 649,7 Tage beziehungsweise um 46,1 Tage. Mehr Geld ist gebunden.

Einordnung der Multiplikatoren

Die Multiplikatoren von Завод ДИОД sind relativ zur aktuellen Qualität anspruchsvoll. Deutliche Verbesserung ist zur Rechtfertigung nötig.

Kennzahlen Jährlich Завод ДИОД

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Price Earnings Ratio, P/E	-13	-4	171.2	17.39	8.02	18.37	6.76	34.25	-17.77	-2.12	-3.2	5.41	-2.3	46.55	11.82	18.46	7.83	0.0	0.0
Price Sales Ratio, P/S	2	2	2.63	1.25	1.21	1.32	0.66	0.49	0.56	0.34	0.4	0.24	0.32	0.55	0.97	1.94	1.88	0.0	0.0
Price To Book Ratio, P/B	2	2	1.27	0.58	0.59	0.57	0.36	0.32	0.34	0.21	0.25	0.18	0.22	0.35	0.82	1.65	1.71	0.0	0.0
Price Earnings To Growth Ratio, PEG	-2	-	-2.16	-0.31	0.05	-0.4	0.01	-0.24	0.22	-0.12	0.01	-0.04	0.0	-0.52	-0.55	-0.33	-0.08	-0.0	-
Operating Cash Flow Per Share	0.66	0.71	0.03	0.0	0.0	0.0	1.85	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	15370.93
Free Cash Flow Per Share	0.72	0.63	-0.35	0.0	-0.12	-0.01	1.83	-0.17	0.0	-0.0	1.13	0.57	-0.36	-0.02	-0.07	-0.19	-0.24	-3745.79	15117.49
Cash Per Share	0.11	0.23	0.37	2.29	1.93	1.31	0.33	1.12	0.92	0.99	1.57	0.02	0.15	0.19	0.19	0.42	0.42	3126.89	2527.87
Payout Ratio	-	-	8.63	0.0	0.6	1.04	0.6	3.03	-0.0	-0.0	-0.09	0.42	-0.07	1.67	0.42	0.06	0.07	0.04	-
Dividend Yield	0.11	0.08	0.05	0.0	0.07	0.06	0.09	0.09	0.0	0.0	0.03	0.08	0.03	0.04	0.04	0.0	0.01	45.31	-
Current Ratio	-	-	6.72	7.56	9.22	8.75	5.75	5.02	4.95	5.72	3.11	1.82	2.44	3.76	2.94	2.9	1.73	2.44	2.26
Quick Ratio	-	-	4.22	4.65	5.61	4.92	3.14	2.67	2.12	2.26	1.26	0.8	1.45	2.4	1.97	1.74	0.84	1.18	1.42
Cash Ratio	-	-	0.26	0.87	0.87	0.47	0.03	0.17	0.04	0.06	0.38	0.0	0.02	0.04	0.03	0.08	0.05	0.06	0.06
Days Of Sales Outstanding, DSO	-	-	204.37	-	213.41	251.13	239.58	172.78	114.3	110.19	106.68	104.26	213.96	251.45	182.99	192.83	131.91	108.46	123.35
Days Of Inventory Outstanding, DIO	-	-	466.79	540.78	545.11	767.96	505.37	477.25	467.31	459.56	800.12	470.68	611.43	517.97	279.75	276.4	321.55	313.16	180.94
Days Of Payables Outstanding, DPO	-	-	21.45	21.07	46.49	144.57	141.34	93.18	99.01	39.08	121.37	70.69	55.61	0.34	49.18	17.54	22.52	26.11	11.36
Operating Cycle	-	-	671.16	540.78	758.51	1019.1	744.95	650.03	581.61	569.75	906.8	574.94	825.38	769.42	462.73	469.22	453.47	421.62	304.3
Cash Conversion Cycle	-	-	649.71	519.71	712.02	874.53	603.61	556.85	482.6	530.67	785.43	504.26	769.77	769.08	413.55	451.68	430.95	395.51	292.93
Gross Profit Margin	-	-	0.54	0.57	0.59	0.63	0.54	0.58	0.5	0.45	0.67	0.55	0.65	0.6	0.54	0.51	0.53	0.61	0.58
Operating Profit Margin	-0.07	-0.56	0.0	0.08	0.18	0.14	0.15	0.07	-0.06	0.06	0.1	0.14	0.16	0.14	0.19	0.2	0.34	0.26	0.21
Pretax Profit Margin	-0.14	-0.49	0.02	0.11	0.19	0.11	0.12	0.06	-0.03	-0.15	-0.11	0.06	-0.12	0.02	0.1	0.11	0.26	0.24	0.21
Net Profit Margin	-0.14	-0.48	0.02	0.07	0.15	0.07	0.1	0.01	-0.03	-0.16	-0.12	0.04	-0.14	0.01	0.08	0.11	0.24	0.17	0.14
Effective Tax Rate	-	-	0.37	0.29	0.23	0.39	0.19	0.78	0.39	-0.05	-0.13	0.28	-0.15	0.68	0.25	0.21	0.11	0.26	0.3
Return On Assets, ROA	-0.07	-0.24	0.01	0.03	0.06	0.03	0.04	0.01	-0.02	-0.08	-0.06	0.02	-0.06	0.0	0.04	0.05	0.12	0.13	0.15
Return On Equity, ROE	-0.11	-0.33	0.01	0.03	0.07	0.03	0.05	0.01	-0.02	-0.1	-0.08	0.03	-0.1	0.01	0.07	0.09	0.22	0.22	0.21
Return On Capital Employed, ROCE	-0.08	-0.52	0.0	0.03	0.08	0.06	0.08	0.05	-0.03	0.03	0.06	0.1	0.09	0.06	0.1	0.11	0.22	0.24	0.28
Net Income Per Ebt	1.0	1.0	0.63	0.67	0.79	0.65	0.8	0.23	0.98	1.05	1.13	0.71	1.15	0.54	0.85	0.99	0.91	0.74	0.68
Ebt Per Ebit	1.82	0.87	7.37	1.33	1.07	0.78	0.81	0.83	0.58	-2.71	-1.15	0.44	-0.75	0.15	0.52	0.55	0.78	0.89	1.01
Ebit Per Revenue	-0.07	-0.56	0.0	0.08	0.18	0.14	0.15	0.07	-0.06	0.06	0.1	0.14	0.16	0.14	0.19	0.2	0.34	0.26	0.21
Debt Ratio	0.53	0.46	0.3	0.29	0.03	0.0	0.01	0.05	0.03	0.01	0.01	0.18	0.3	0.3	0.21	0.18	0.17	0.22	0.12
Debt Equity Ratio	-	-	-	-	0.04	0.0	0.01	0.06	0.04	0.01	0.01	0.27	0.51	0.52	0.4	0.34	0.31	0.38	0.17
Long Term Debt To Capitalization	-	-	-	-	-	-	0.03	0.01	0.01	0.01	0.0	0.0	0.17	0.28	0.2	0.17	0.04	0.18	-
Total Debt To Capitalization	-	-	-	-	0.04	0.0	0.01	0.06	0.04	0.01	0.01	0.21	0.34	0.34	0.29	0.25	0.24	0.27	0.14
Interest Coverage	-	-	-	1222.43	5633.42	127.13	28.15	-	-1.98	1.33	0.82	1.95	1.83	1.67	3.25	3.23	4.52	10.37	164.81
Cash Flow To Debt Ratio	-	-	-	-	0.0	0.07	21.21	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.77
Company Equity Multiplier	2.11	1.85	1.19	1.17	1.15	1.16	1.2	1.21	1.21	1.19	1.31	1.5	1.7	1.72	1.96	1.84	1.81	1.72	1.45
Receivables Turnover	-	-	1.79	-	1.71	1.45	1.52	2.11	3.19	3.31	3.42	3.5	1.71	1.45	1.99	1.89	2.77	3.37	2.96
Payables Turnover	-	-	17.01	17.32	7.85	2.52	2.58	3.92	3.69	9.34	3.01	5.16	6.56	1063.66	7.42	20.81	16.21	13.98	32.12
Inventory Turn Over	-	-	0.78	0.67	0.67	0.48	0.72	0.76	0.78	0.79	0.46	0.78	0.6	0.7	1.3	1.32	1.14	1.17	2.02
Fixed Asset Turnover	-	-	2.2	2.16	2.23	1.93	2.39	3.12	3.12	3.28	3.42	4.38	3.74	3.62	3.17	3.42	3.52	4.31	4.23
Asset Turnover	0.54	0.5	0.41	0.4	0.42	0.37	0.45	0.54	0.51	0.53	0.47	0.51	0.41	0.37	0.43	0.46	0.5	0.74	1.03
Operating Cash Flow Sales Ratio	0.12	0.13	0.01	0.0	0.0	0.0	0.26	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.09
Free Cash Flow Operating Cash Flow Ratio	0.98	0.51	-10.39	0.97	-103.26	-10.64	0.99	-295.91	0.62	1.02	-	-	-	-	-	-	-	-	0.98
Cash Flow Coverage Ratios	-	-	-	-	0.0	0.07	21.21	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.77
Short Term Coverage Ratios	-	-	-	-	0.02	0.07	21.21	0.0	0.0	-0.01	-	-	-	-	-	-	-	-	0.77
Capital Expenditure Coverage Ratio	60.0	2.03	0.09	36.09	0.01	0.09	83.3	0.0	2.61	-41.64	-	-	-	-	-	-	-	-	60.65
Dividend Paid And Capex Coverage Ratio	0.58	0.62	0.03	1.38	0.0	0.0	4.18	0.0	1.19	-41.22	-	-	-	-	-	-	-	-	60.65
Dividend Payout Ratio	-	-	8.63	0.0	0.6	1.04	0.6	3.03	-0.0	-0.0	-0.09	0.42	-0.07	1.67	0.42	0.06	0.07	0.04	-
Price To Free Cash Flows Ratio, P/FCF	16.1	29.09	-45.1	7196.53	-67.86	-719.95	2.58	-24.09	9568.71	-3567.51	3.71	5.91	-10.84	-387.96	-232.77	-171.45	-132.63	-0.01	0.0
Price To Operating Cash Flows Ratio, P/OCF	15.83	14.77	468.51	6997.11	7007.48	7657.5	2.55	7128.65	5897.15	-3653.19	-	-	-	-	-	-	-	-	0.0
Price Cash Flow Ratio, P/CF	15.83	14.77	468.51	6997.11	7007.48	7657.5	2.55	7128.65	5897.15	-3653.19	-	-	-	-	-	-	-	-	0.0
Enterprise Value Multiple, EV	-34	-4	62.85	9.12	5.22	8.22	4.02	4.62	14.36	-4.61	20.81	4.11	186.13	10.26	8.9	13.84	6.0	1.08	0.44
Price Fair Value, P/FV	2	2	1.27	0.58	0.59	0.57	0.36	0.32	0.34	0.21	0.25	0.18	0.22	0.35	0.82	1.65	1.71	0.0	0.0

Alle Zahlen in RUB-Währung

Kennzahlen Vierteljährlich Завод ДИОД

	2023-Q2	2022-Q4	2022-Q2	2021-Q4	2021-Q2	2020-Q4	2020-Q2	2019-Q4	2019-Q2	2018-Q4	2018-Q2	2017-Q4	2017-Q2	2016-Q4	2016-Q2	2015-Q4	2015-Q2	2014-Q4	2014-Q2	2013-Q4	2013-Q2	2011-Q4	2011-Q2	2010-Q4	2010-Q2	2009-Q4	2009-Q2	2008-Q4	2008-Q2
Price Earnings Ratio, P/E	69.1	6.56 K	12	6.38	3.72	5.6	15.9	14.3	1.99	-10.2	5.66	-1.93	2.64	-2.18	-0.813	-1.21	-2.36	2.7	3.38	8.69	-1.13	5.91	8.06	9.23	8.68	3.92	3.92	0.001	0.0
Price Sales Ratio, P/S	4.24	2.7 K	2.47	2.48	3	2.19	2.35	1.35	1.35	0.987	1.18	1.26	0.795	0.723	0.733	0.7	0.93	0.482	0.603	0.565	1.51	1.95	2.66	3.88	3.64	3.76	3.76	0.0	0.0
Price To Book Ratio, P/B	1.01	0.582	0.632	0.588	0.767	0.541	0.419	0.357	0.379	0.322	0.346	0.345	0.256	0.211	0.239	0.247	0.236	0.184	0.236	0.222	0.229	0.816	1.12	1.65	1.6	1.71	1.9	-	0.0
Price Earnings To Growth Ratio, PEG	0.003	-65.7	-0.265	-0.117	0.033	0.022	1.75	-0.165	-0.003	0.07	-0.043	0.007	-0.013	0.032	-0.023	-0.013	0.01	-	0.019	-0.077	0.001	-	-0.377	-	-0.154	-	-0.039	-	-0.0
Operating Cash Flow Per Share	0.017	0.0	0.72	0.405	0.762	0.627	0.342	0.491	1.39	0.56	-	0.001	-0.0	-0.0	-0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow Per Share	-0.175	0.0	0.711	0.344	0.704	0.616	0.342	0.541	1.31	0.528	-0.087	0.001	-0.0	-0.0	-0.0	0.566	0.566	0.286	0.286	-0.182	-0.182	-0.035	-0.035	-0.096	-0.096	-0.121	-0.121	-936	-1.87 K
Cash Per Share	2.52	2.3	2.66	1.93	2.12	1.37	0.699	0.334	1.4	1.11	1.04	0.921	1.03	0.991	1.38	1.57	0.046	0.02	0.161	0.154	0.228	0.189	0.302	0.415	0.418	0.42	0.367	-	2.83 K
Payout Ratio	8.63	2.62	0.0	1.88	0.005	1.33	-	5.13	0.17	-3.56	0.819	-0.001	-	-0.0	-	-0.068	-0.133	0.425	0.425	0.538	-0.067	0.422	0.422	0.063	0.063	0.065	0.065	0.029	0.044
Dividend Yield	0.031	0.0	0.0	0.074	0.0	0.059	-	0.089	0.021	0.088	0.036	0.0	-	0.0	-	0.014	0.014	0.039	0.031	0.015	0.015	0.018	0.013	0.002	0.002	0.004	0.004	11.3	22.7
Current Ratio	5	7.56	5.58	9.22	5.84	8.75	6.53	5.75	5.24	5.02	4.52	4.95	4.2	5.72	2.55	3.11	1.88	1.82	1.88	2.44	3.06	2.94	2.92	2.9	2.21	1.73	2.01	-	2.35
Quick Ratio	3.23	4.65	3.41	5.61	3.51	4.92	3.69	3.14	2.63	2.67	2.1	2.12	2.02	2.26	1.31	1.26	0.714	0.796	1.08	1.45	1.83	1.97	1.87	1.74	1.21	0.838	0.972	-	1.29
Cash Ratio	0.643	0.874	0.839	0.872	0.643	0.474	0.231	0.025	0.305	0.166	0.088	0.041	0.055	0.061	0.087	0.385	0.007	0.002	0.019	0.021	0.037	0.031	0.052	0.077	0.063	0.054	0.057	-	0.06
Days Of Sales Outstanding, DSO	-	126 K	89	108	105	117	139	121	74.6	85.7	62.6	62.8	71.8	58.3	101	46.2	65	-	-	-	-	90.2	92.6	95.1	80.3	65.1	62.2	-	55.3
Days Of Inventory Outstanding, DIO	240	274 K	255	239	311	318	476	324	222	226	291	245	230	241	231	272	487	232	187	259	743	138	141	136	145	159	151	-	122
Days Of Payables Outstanding, DPO	37.9	10.7 K	12.3	20.4	10.9	59.9	74.2	90.6	13.5	44.1	15.2	52	30	20.5	115	41.3	84.9	34.9	26	23.5	97.9	24.3	16.7	8.65	9.68	11.1	11.5	-	9.25
Operating Cycle	240	401 K	344	347	416	436	615	445	296	312	354	308	302	300	331	319	552	232	187	259	743	228	234	231	225	224	213	-	177
Cash Conversion Cycle	202	390 K	332	326	405	376	540	354	283	267	339	256	272	279	217	277	467	197	161	235	645	204	217	223	215	213	202	-	168
Gross Profit Margin	0.536	0.547	0.566	0.53	0.632	0.618	0.642	0.642	0.437	0.555	0.596	0.478	0.52	0.448	0.455	0.584	0.668	0.546	0.546	0.635	0.665	0.541	0.541	0.514	0.514	0.534	0.534	0.583	0.611
Operating Profit Margin	0.003	0.108	0.061	0.056	0.242	0.131	0.04	0.073	0.083	0.015	0.13	-0.19	0.053	-0.026	0.127	0.165	0.003	0.143	0.143	0.145	0.182	0.188	0.188	0.195	0.195	0.336	0.336	0.205	0.264
Pretax Profit Margin	0.024	0.126	0.09	0.119	0.258	0.141	0.069	0.089	0.155	0.045	0.075	-0.176	0.084	-0.039	-0.25	-0.059	-0.177	0.063	0.063	0.034	-0.317	0.097	0.097	0.107	0.107	0.263	0.263	0.206	0.236
Net Profit Margin	0.015	0.103	0.052	0.097	0.202	0.098	0.037	0.023	0.169	-0.024	0.052	-0.163	0.075	-0.083	-0.225	-0.144	-0.098	0.045	0.045	0.016	-0.335	0.082	0.082	0.105	0.105	0.24	0.24	0.141	0.175
Effective Tax Rate	0.372	0.227	0.375	0.252	0.217	0.369	0.449	0.719	-0.097	1.42	0.401	0.219	0.096	-1.19	0.207	-1.43	0.903	0.281	0.281	0.489	-0.062	0.252	0.252	0.215	0.215	0.112	0.112	0.301	0.259
Return On Assets, ROA	0.003	0.0	0.011	0.02	0.043	0.021	0.006	0.005	0.039	-0.007	0.012	-0.037	0.019	-0.02	-0.051	-0.039	-0.017	0.011	0.011	0.004	-0.03	0.018	0.018	0.024	0.025	0.06	0.069	-	0.077
Return On Equity, ROE	0.004	0.0	0.013	0.023	0.051	0.024	0.007	0.006	0.048	-0.008	0.015	-0.045	0.024	-0.024	-0.073	-0.051	-0.025	0.017	0.017	0.006	-0.051	0.035	0.035	0.045	0.046	0.109	0.121	-	0.123
Return On Capital Employed, ROCE	0.001	0.0	0.015	0.012	0.058	0.03	0.007	0.018	0.022	0.005	0.035	-0.049	0.016	-0.007	0.039	0.054	0.001	0.051	0.049	0.045	0.02	0.048	0.049	0.053	0.058	0.11	0.122	-	0.149
Net Income Per Ebt	0.628	0.815	0.574	0.817	0.781	0.695	0.532	0.264	1.09	-0.538	0.693	0.929	0.896	2.13	0.901	2.44	0.555	0.705	0.705	0.484	1.06	0.851	0.851	0.985	0.985	0.912	0.912	0.684	0.741
Ebt Per Ebit	7.37	1.17	1.47	2.13	1.07	1.07	1.71	1.23	1.88	2.94	0.581	0.923	1.6	1.5	-1.97	-0.359	-56.3	0.442	0.442	0.232	-1.75	0.516	0.516	0.545	0.545	0.783	0.783	1.01	0.894
Ebit Per Revenue	0.003	0.108	0.061	0.056	0.242	0.131	0.04	0.073	0.083	0.015	0.13	-0.19	0.053	-0.026	0.127	0.165	0.003	0.143	0.143	0.145	0.182	0.188	0.188	0.195	0.195	0.336	0.336	0.205	0.264
Debt Ratio	-	-	0.0	0.033	-	0.001	0.029	0.006	0.026	0.05	0.041	0.034	0.023	0.01	0.008	0.011	0.17	0.179	0.238	0.299	0.323	0.205	0.195	0.183	0.177	0.171	0.192	-	0.178
Debt Equity Ratio	-	-	0.0	0.038	-	0.001	0.035	0.007	0.032	0.061	0.05	0.041	0.028	0.012	0.012	0.015	0.248	0.27	0.382	0.507	0.551	0.402	0.37	0.337	0.324	0.31	0.34	-	0.284
Long Term Debt To Capitalization	-	-	-	0.033	-	-	0.027	0.027	0.006	0.006	0.006	0.005	0.005	0.005	0.005	0.005	0.005	0.004	0.06	0.173	0.231	0.199	0.186	0.173	0.115	0.042	0.111	-	0.112
Total Debt To Capitalization	-	-	0.0	0.037	-	0.001	0.034	0.007	0.031	0.057	0.048	0.039	0.028	0.012	0.012	0.014	0.199	0.213	0.276	0.336	0.355	0.287	0.27	0.252	0.245	0.237	0.254	-	0.221
Interest Coverage	-	-	-	28.8	176	-	-	0.055	0.012	-	-	-3	-	-	-	-	-	1.95	1.95	-	-	3.25	3.25	3.23	3.23	4.52	4.52	165	10.4
Cash Flow To Debt Ratio	-	-	1.58 K	0.787	-	47.2	0.723	5.59	3.3	0.725	-	0.002	-0.001	-0.002	-0.002	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Company Equity Multiplier	1.25	1.17	1.22	1.15	1.21	1.16	1.18	1.2	1.21	1.21	1.23	1.21	1.24	1.19	1.43	1.31	1.46	1.5	1.6	1.7	1.71	1.96	1.9	1.84	1.83	1.81	1.77	-	1.6
Receivables Turnover	-	0.001	1.01	0.834	0.855	0.767	0.648	0.745	1.21	1.05	1.44	1.43	1.25	1.54	0.895	1.95	1.38	-	-	-	-	0.997	0.972	0.946	1.12	1.38	1.45	-	1.63
Payables Turnover	2.37	0.008	7.33	4.42	8.25	1.5	1.21	0.994	6.66	2.04	5.9	1.73	3	4.39	0.784	2.18	1.06	2.58	3.46	3.82	0.919	3.71	5.39	10.4	9.3	8.11	7.81	-	9.73
Inventory Turn Over	0.376	0.0	0.353	0.377	0.29	0.283	0.189	0.278	0.406	0.398	0.309	0.367	0.392	0.373	0.39	0.33	0.185	0.388	0.481	0.348	0.121	0.652	0.638	0.66	0.622	0.568	0.596	-	0.737
Fixed Asset Turnover	1.07	0.001	1.15	1.09	1.15	1.11	0.802	1.17	1.3	1.55	1.5	1.4	1.71	1.53	1.71	1.95	1.45	2.19	2.15	2.1	0.804	1.59	1.65	1.71	1.73	1.76	1.85	-	2.2
Asset Turnover	0.191	0.0	0.21	0.207	0.212	0.214	0.151	0.222	0.233	0.27	0.238	0.227	0.259	0.245	0.228	0.269	0.174	0.254	0.245	0.232	0.089	0.214	0.222	0.231	0.24	0.251	0.286	-	0.441
Operating Cash Flow Sales Ratio	0.006	0.149	0.218	0.126	0.226	0.197	0.14	0.14	0.373	0.135	-	0.0	-0.0	-0.0	-0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow Operating Cash Flow Ratio	-10.4	0.95	0.987	0.851	0.924	0.982	1	1.1	0.948	0.942	-	0.757	1.27	1	1.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Coverage Ratios	-	-	1.58 K	0.787	-	47.2	0.723	5.59	3.3	0.725	-	0.002	-0.001	-0.002	-0.002	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Coverage Ratios	-	-	-	8.68	-	47.2	3.68	5.59	4.12	0.809	-	0.002	-0.001	-0.004	-0.004	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital Expenditure Coverage Ratio	0.088	0.02	77.5	6.69	13.2	56.5	-	9.97	19.1	17.1	-	4.11	-3.71	-	-20.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Paid And Capex Coverage Ratio	0.029	0.019	77	0.625	12.4	1.47	-	1.04	7.73	1.43	-	1.66	-3.71	-2.06 K	-20.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.63	2.62	0.0	1.88	0.005	1.33	-	5.13	0.17	-3.56	0.819	-0.001	-	-0.0	-	-0.068	-0.133	0.425	0.425	0.538	-0.067	0.422	0.422	0.063	0.063	0.065	0.065	0.029	0.044
Price To Free Cash Flows Ratio, P/FCF	-72.8	19.1 K	11.5	23.1	14.4	11.3	16.7	8.75	3.81	7.79	-58.8	6.12 K	-13.2 K	-7.24 K	-8.18 K	7.42	7.45	11.8	14.8	-21.7	-22.7	-466	-635	-343	-322	-265	-265	-0.034	-0.017
Price To Operating Cash Flows Ratio, P/OCF	757	18.2 K	11.3	19.7	13.3	11.1	16.7	9.62	3.61	7.34	-	4.63 K	-16.8 K	-7.24 K	-8.58 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Price Cash Flow Ratio, P/CF	757	18.2 K	11.3	19.7	13.3	11.1	16.7	9.62	3.61	7.34	-	4.63 K	-16.8 K	-7.24 K	-8.58 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Enterprise Value Multiple, EV	92.9	17.2 K	20.9	29.5	9.19	9.17	27.9	17.3	9.91	23.1	7.05	-21.1	6.46	22.8	5.4	-3.67	96.3	8.22	10.8	10.8	23.6	17.8	21.6	27.7	25.9	12	12	-	1.43
Price Fair Value, P/FV	1.01	0.582	0.632	0.588	0.767	0.541	0.419	0.357	0.379	0.322	0.346	0.345	0.256	0.211	0.239	0.247	0.236	0.184	0.236	0.222	0.229	0.816	1.12	1.65	1.6	1.71	1.9	-	0.0

Alle Zahlen in RUB-Währung

Multiplikatoren sind ein wichtiges Instrument der Finanzanalyse für das Unternehmen Завод ДИОД, das es Investoren und Analysten ermöglicht, den Unternehmenswert und die Investitionsattraktivität schnell anhand des Verhältnisses von Marktindikatoren zu den finanziellen Ergebnissen des Unternehmens zu bewerten. Im Wesentlichen drücken Multiplikatoren aus, wie der Markt das Unternehmen im Verhältnis zu seinem Gewinn, Umsatz, Eigenkapital oder anderen wichtigen Kennzahlen bewertet.

Vorteile der Verwendung von Finanzkennzahlen

Vereinfachte Datenanalyse
Finanzkennzahlen verwandeln große Mengen an Buchhaltungsdaten in kompakte und leicht interpretierbare Indikatoren, was die Beurteilung des Unternehmenszustands erheblich vereinfacht.
Vergleichbarkeit zwischen Unternehmen
Multiplikatoren standardisieren Finanzkennzahlen und ermöglichen so einen objektiven Vergleich von Unternehmen unterschiedlicher Größe, Branche und Marktkapitalisierung.
Erkennung von Trends und Problemen
Die regelmäßige Analyse von Kennzahlen hilft, die Entwicklung der finanziellen Gesundheit zu verfolgen, Stärken und Schwächen des Geschäfts sowie potenzielle Risiken zu identifizieren.
Entscheidungsunterstützung
Finanzielle Multiplikatoren dienen Investoren, Gläubigern und der Unternehmensführung als wichtiges Instrument bei Investitions-, Kredit- und Managemententscheidungen.
Beschleunigte Bewertung der Investitionsattraktivität
Mit Hilfe von Kennzahlen können schnell wichtige Leistungs-, Liquiditäts- und Finanzstabilitätsindikatoren bestimmt werden, was eine zügige Bewertung der Attraktivität von Unternehmen für Investitionen ermöglicht.

Die Verwendung von Multiplikatoren ermöglicht den Vergleich von Unternehmen, auch wenn sie sich in Größe oder Branche unterscheiden, da sie Finanzdaten in für die Analyse geeignete Kennzahlen standardisieren. Dies ist besonders nützlich zur Bewertung von Unternehmen, bei denen eine direkte Analyse der Finanzberichte komplex sein kann oder tiefgehendes Fachwissen erfordert.

Finanzkennzahlen anderer Aktien in der Pharmaeinzelhändler

Name	Preis	% 24h	Marktkapitalisierung	Land
Институт стволовых клеток человека ISKJ	-	-	-	Russia
ММЦБ GEMA	-	-	-	Russia
Lyra Therapeutics LYRA	-	-	$ 24.9 M	USA
ОЗОН Фармацевтика OZPH	-	-	-	Russia
Промомед PRMD	-	-	-	Russia
Brickell Biotech BBI	-	-5.38 %	$ 6.06 M	USA
Applied Therapeutics APLT	-	-	$ 8.42 M	USA
ESSA Pharma EPIX	-	-	$ 8.86 M	Canada
Generation Bio Co. GBIO	-	-	$ 344 M	USA
Clearside Biomedical CLSD	-	-	$ 25.3 M	USA
Merus N.V. MRUS	-	-	$ 5.78 B	Niderland
RAPT Therapeutics RAPT	-	-	$ 2.36 B	USA
Annexon ANNX	$ 4.0	-7.62 %	$ 620 M	USA
Alnylam Pharmaceuticals ALNY	$ 156.5	-2.85 %	$ 20.5 B	USA
Amgen AMGN	$ 462.71	-3.3 %	$ 249 B	USA
Theratechnologies THTX	-	-	$ 83.9 M	Canada
Iovance Biotherapeutics IOVA	$ 7.72	-11.26 %	$ 2.76 M	USA
Biogen BIIB	$ 243.85	-4.17 %	$ 35.7 B	USA
Ironwood Pharmaceuticals IRWD	$ 4.03	6.9 %	$ 652 M	USA
Armata Pharmaceuticals ARMP	$ 3.01	-4.14 %	$ 109 M	USA
Mustang Bio MBIO	$ 0.39	-5.63 %	$ 1.91 M	USA
MannKind Corporation MNKD	$ 3.77	-4.07 %	$ 1.15 B	USA
InflaRx N.V. IFRX	$ 1.36	-8.11 %	$ 91.5 M	Germany
Immutep Limited IMMP	$ 2.7	-8.47 %	$ 3.93 B	Australia
Insmed Incorporated INSM	$ 108.79	-1.1 %	$ 21.7 B	USA
Titan Pharmaceuticals TTNP	-	-3.76 %	$ 3.47 M	USA
Jazz Pharmaceuticals plc JAZZ	$ 227.25	-3.16 %	$ 13.9 B	Irlanda
BioLineRx Ltd. BLRX	$ 1.77	-4.95 %	$ 4.36 B	Israel
Bristol-Myers Squibb Company BMY	$ 63.15	-1.64 %	$ 128 B	USA
Johnson & Johnson JNJ	$ 272.47	-1.4 %	$ 656 B	USA
Allena Pharmaceuticals ALNA	-	3.16 %	$ 1.9 M	USA
PainReform Ltd. PRFX	$ 0.76	-1.27 %	$ 492 K	Israel
Kala Pharmaceuticals KALA	$ 0.15	-13.14 %	$ 1.22 M	USA
Prothena Corporation plc PRTA	$ 7.9	-5.84 %	$ 425 M	USA
TCR2 Therapeutics TCRR	-	-	$ 58.1 M	USA
Dr. Reddy's Laboratories Limited RDY	$ 14.53	-1.63 %	$ 12.1 B	India
Keros Therapeutics KROS	$ 9.42	-13.02 %	$ 351 M	USA
Crinetics Pharmaceuticals CRNX	$ 84.95	0.13 %	$ 7.99 B	USA
Kazia Therapeutics Limited KZIA	$ 7.13	-11.76 %	$ 109 M	Australia
TFF Pharmaceuticals TFFP	-	-60.05 %	$ 125 K	USA
Sana Biotechnology SANA	$ 2.32	-9.38 %	$ 588 M	USA
Lineage Cell Therapeutics LCTX	$ 0.98	-4.85 %	$ 226 M	USA
Ligand Pharmaceuticals Incorporated LGND	$ 298.8	-5.48 %	$ 5.78 B	USA
Longeveron LGVN	$ 1.76	-1.12 %	$ 30.9 B	USA
Eli Lilly and Company LLY	$ 1 366.97	-3.62 %	$ 1.23 T	USA
Adaptimmune Therapeutics plc ADAP	-	-15.15 %	$ 60.3 M	Britain
AVEO Pharmaceuticals AVEO	-	-	$ 521 M	USA
CollPlant Biotechnologies Ltd. CLGN	$ 4.01	-5.2 %	$ 48.9 M	Israel
Axcella Health AXLA	-	-16.42 %	$ 249 M	USA
Compugen Ltd. CGEN	$ 1.94	-4.68 %	$ 181 M	Israel

Завод ДИОД Kennzahlen 2025-2007 | DIOD

Kurzer Überblick über die Finanzkennzahlen von Завод ДИОД

Einordnung der Multiplikatoren

Kennzahlen Jährlich Завод ДИОД

Price Earnings Ratio, P/E

Price Sales Ratio, P/S

Price To Book Ratio, P/B

Price Earnings To Growth Ratio, PEG

Operating Cash Flow Per Share

Free Cash Flow Per Share

Cash Per Share

Payout Ratio

Dividend Yield

Current Ratio

Quick Ratio

Cash Ratio

Days Of Sales Outstanding, DSO

Days Of Inventory Outstanding, DIO

Days Of Payables Outstanding, DPO

Operating Cycle

Cash Conversion Cycle

Gross Profit Margin

Operating Profit Margin

Pretax Profit Margin

Net Profit Margin

Effective Tax Rate

Return On Assets, ROA

Return On Equity, ROE

Return On Capital Employed, ROCE

Net Income Per Ebt

Ebt Per Ebit

Ebit Per Revenue

Debt Ratio

Debt Equity Ratio

Long Term Debt To Capitalization

Total Debt To Capitalization

Interest Coverage

Cash Flow To Debt Ratio

Company Equity Multiplier

Receivables Turnover

Payables Turnover

Inventory Turn Over

Fixed Asset Turnover

Asset Turnover

Operating Cash Flow Sales Ratio

Free Cash Flow Operating Cash Flow Ratio

Cash Flow Coverage Ratios

Short Term Coverage Ratios

Capital Expenditure Coverage Ratio

Dividend Paid And Capex Coverage Ratio

Dividend Payout Ratio

Price To Free Cash Flows Ratio, P/FCF

Price To Operating Cash Flows Ratio, P/OCF

Price Cash Flow Ratio, P/CF

Enterprise Value Multiple, EV

Price Fair Value, P/FV

Jährliche Entwicklung